120 related articles for article (PubMed ID: 37196546)
1. Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Cardoso MMA; Thabane L; Andrade LGM; Curado DDSP; Komoda DS; Machado-Rugolo J; Lima SAM; Weber SAT
Value Health Reg Issues; 2023 Sep; 37():18-22. PubMed ID: 37196546
[TBL] [Abstract][Full Text] [Related]
2. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
3. Horizon scanning in Brazil: outputs and repercussions.
Gomes PTC; Mata VE; Borges TC; Galato D
Rev Saude Publica; 2019; 53():111. PubMed ID: 31800908
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients?
Biglia LV; Mendes SJ; Lima TM; Aguiar PM
Cien Saude Colet; 2021 Nov; 26(11):5547-5560. PubMed ID: 34852089
[TBL] [Abstract][Full Text] [Related]
5. Does patient and public involvement impact public health decision-making? A 10 year retrospective analysis of public consultation in Brazil.
De Freitas Lopes AC; Novaes HMD; De Soárez PC
Health Res Policy Syst; 2023 Jul; 21(1):72. PubMed ID: 37438823
[TBL] [Abstract][Full Text] [Related]
6. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
8. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
9. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
10. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
Caetano R; Hauegen RC; Osorio-de-Castro CGS
Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
[TBL] [Abstract][Full Text] [Related]
11. [Does the pharmaceutical industry interfere in the sustainability of the public health system in Brazil? A reflection on the pressure for the incorporation of medicines].
Tamachiro ST; Gonçalves FAR; Simone ALM; Aguiar PM
Cad Saude Publica; 2022; 38(7):e00233321. PubMed ID: 35894368
[TBL] [Abstract][Full Text] [Related]
12. Decision criteria for resource allocation: an analysis of CONITEC oncology reports.
Campolina AG; Yuba TY; Soárez PC
Cien Saude Colet; 2022 Jul; 27(7):2563-2572. PubMed ID: 35730828
[TBL] [Abstract][Full Text] [Related]
13. Patient and public involvement in health technology decision-making processes in Brazil.
Lopes ACF; Novaes HMD; Soárez PC
Rev Saude Publica; 2020; 54():136. PubMed ID: 33331420
[TBL] [Abstract][Full Text] [Related]
14. Making the COVID-19 Pandemic a Driver for Digital Health: Brazilian Strategies.
Donida B; da Costa CA; Scherer JN
JMIR Public Health Surveill; 2021 Jun; 7(6):e28643. PubMed ID: 34101613
[TBL] [Abstract][Full Text] [Related]
15. The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.
de Lemos LLP; Guerra Júnior AA; Santos M; Magliano C; Diniz I; Souza K; Pereira RG; Alvares J; Godman B; Bennie M; Zimmermann IR; Dos Santos VCC; Pretramale CA; Acurcio FA
Pharmacoeconomics; 2018 Feb; 36(2):161-173. PubMed ID: 29139001
[TBL] [Abstract][Full Text] [Related]
16. Social participation in the health technology incorporation process into Unified Health System.
Silva AS; Sousa MSA; Silva EVD; Galato D
Rev Saude Publica; 2019; 53():109. PubMed ID: 31859904
[TBL] [Abstract][Full Text] [Related]
17. Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic.
VanderWerf M; Bernard J; Barta DT; Berg J; Collins T; Dowdy M; Feiler K; Moore DL; Sifri C; Spargo G; Taylor CW; Towle CB; Wibberly KH
Telemed J E Health; 2022 Apr; 28(4):443-456. PubMed ID: 34265217
[No Abstract] [Full Text] [Related]
18. Health technology assessment and judicial deference to priority-setting decisions in healthcare: Quasi-experimental analysis of right-to-health litigation in Brazil.
Wang D; Vasconcelos NP; Poirier MJ; Chieffi A; Mônaco C; Sritharan L; Van Katwyk SR; Hoffman SJ
Soc Sci Med; 2020 Nov; 265():113401. PubMed ID: 33250316
[TBL] [Abstract][Full Text] [Related]
19. Two years of COVID-19 pandemic: Framework of health interventions in a Brazilian city.
Faiões VDS; Póvoa HCC; Thurler BA; Chianca GC; Assaf AV; Iorio NLPP
Front Public Health; 2022; 10():1025410. PubMed ID: 36388316
[TBL] [Abstract][Full Text] [Related]
20. Reversal of the recommendations issued by the National Commission for the Incorporation of Technologies in SUS after Public Consultations.
Lopes SGP; Luiza VL; Silva RMD
Cien Saude Colet; 2023 Feb; 28(2):561-573. PubMed ID: 36651407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
